Dr. Weber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
160 East 34th Street
7th Floor
New York, NY 10016- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1980 - 1981
- New York University School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1994 - Present
- NY State Medical License 1983 - 2025
- FL State Medical License 2007 - 2017
- MD State Medical License 1985 - 1995
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase I/II Study of Dasatinib and Dacarbazine Start of enrollment: 2007 Nov 01
- Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma Start of enrollment: 2009 Jan 23
- Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 Start of enrollment: 2009 Oct 01
- Join now to see all
Publications & Presentations
Journal Articles
- The Society for Immunotherapy of Cancer Perspective on Regulation of Interleukin-6 Signaling in COVID-19-Related Systemic Inflammatory ResponseSteven J O'Day, Walter J Urba, Jeffrey S Weber, Journal For Immunotherapy of Cancer
Lectures
- Serum IL-6 and CRP as prognostic factors in melanoma patients receiving single agent and combination checkpoint inhibition.2019 ASCO Annual Meeting - 6/1/2019
- Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: Updated results from a phase III trial (CheckMate 238).2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- NYU Langone Health in the News—Monday, May 8, 2023May 8th, 2023
- Personalized mRNA Vaccine Boosts Immunotherapy for High-Risk MelanomaApril 19th, 2023
- Merck’s Keytruda Scores Triple Hit at AACRApril 19th, 2023
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: